doi:10.3969/j.issn.1671-2587.2019.02.004

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2019, Vol. 21 ›› Issue (2): 124-129.DOI: 10.3969/j.issn.1671-2587.2019.02.004

• Orginal Article • Previous Articles Next Articles

Received:2018-10-11 Online:2019-04-20 Published:2019-04-10

1 Mairb?url H，Weber R E. Oxygen transport by hemoglobin[J]. Compr Physiol，2012，2（2）：1463-1489.
2 朱大年，王庭槐. 生理学[M]. 第8版. 北京:人民卫生出版社，2013：170-176.
3 Brunori M. Variations on the theme: allosteric control in hemoglobin[J]. FEBS J，2014，281（2）：633-43.
4 Srinivasan A J，Morkane C，Martin D S，et al. Should modulation of p50 be a therapeutic target in the critically ill?[J]. Expert Rev Hematol，2017，10（5）：449-458.
5 Li Q，Ma H，Zhang Y，et al. Study on oxidation stability and oxygen affinity of hemoglobin during storage[J]. Artif Organs，2018，42（12）：1185-1195.
6 Malte H，Lykkeboe G. The Bohr/Haldane effect: A model based uncovering of the full extent of its impact on O2 delivery to and CO2 removal from tissues[J]. J Appl Physiol (1985)，2018，125（3）：916-922.
7 Li C，Li X，Liu J，et al. Investigation of the differences between the Tibetan and Han populations in the hemoglobin-oxygen affinity of red blood cells and in the adaptation to high-altitude environments[J]. Hematology，2018，23（5）：309-313.
8 Gladwin M T，Kim-Shapiro D B. The functional nitrite reductase activity of the heme-globins[J]. Blood，2008，112（7）：2636-2647.
9 Nakagawa A，Lui F E，Wassaf D，et al. Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling[J]. ACS Chem Biol，2014，9（10）：2318-2325.
10 Gell D A. Structure and function of haemoglobins[J]. Blood Cells Mol Dis，2018，70：13-42.
11 Helms C C，Gladwin M T，Kim-Shapiro D B. Erythrocytes and Vascular Function: Oxygen and Nitric Oxide[J]. Front Physiol，2018，9：125.
12 García-Roa M，Del CVM，Bobes A M，et al. Red blood cell storage time and transfusion: current practice，concerns and future perspectives[J]. Blood Transfus，2017，15（3）：222-231.
13 Li Y，Xiong Y，Wang R，et al. Blood banking-induced alteration of red blood cell oxygen release ability[J]. Blood Transfus，2016，14（2）：238-244.
14 Srinivasan A J，Kausch K，Inglut C，et al. Estimation of Achievable Oxygen Consumption Following Transfusion With Rejuvenated Red Blood Cells[J]. Semin Thorac Cardiovasc Surg，2018，30（2）：134-141.
15 Aujla H，Woniak M，Kumar T，et al. Rejuvenation of allogenic red cells: benefits and risks[J]. Vox Sang，2018，113（6）：509-529.
16 Wo niak M J，Qureshi S，Sullo N，et al. A comparison of red cell rejuvenation versus mechanical washing for the prevention of transfusion-associated organ Injury in Swine[J]. Anesthesiology，2018，128（2）：375-385.
17 Avellan-Hietanen H，Aittomaki J，Ekroos H，et al. Decreased oxygen saturation as a result of haemoglobin Titusville[J]. Clin Respir J，2008，2（4）：242-244.
18 Oliveira J L，Coon L M，Frederick L A，et al. Genotype-phenotype correlation of hereditary erythrocytosis mutations，a single center experience[J]. Am J Hematol，2018.
19 Orvain C，Joly P，Pissard S，et al. Diagnostic approach to hemoglobins with high oxygen affinity: experience from France and Belgium and review of the literature[J]. Ann Biol Clin (Paris)，2017，75（1）：39-51.
20 Mangin O. High oxygen affinity hemoglobins[J]. Rev Med Interne，2017，38（2）：106-112.
21 Metcalf B，Chuang C，Dufu K，et al. Discovery of GBT440，an orally bioavailable R-state stabilizer of sickle cell hemoglobin[J]. ACS Med Chem Lett，2017，8（3）：321-326.
22 Bourgeaux V，Hequet O，Campion Y，et al. Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling[J]. Transfusion，2010，50（10）：2176-2184.
23 Bourgeaux V，Aufradet E，Campion Y，et al. Efficacy of homologous inositol hexaphosphate-loaded red blood cells in sickle transgenic mice[J]. Br J Haematol，2012，157（3）：357-369.
24 Safo M K，Kato G J. Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin[J]. Hematol Oncol Clin North Am，2014，28（2）：217-231.
25 Kassa T，Strader M B，Nakagawa A，et al. Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects[J]. Metallomics，2017，9（9）：1260-1270.
26 Nakagawa A，Ferrari M，Schleifer G，et al. A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells[J]. Mol Pharm，2018，15（5）：1954-1963.
27 Oksenberg D，Dufu K，Patel M P，et al. GBT440 increases haemoglobin oxygen affinity，reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease[J]. Br J Haematol，2016，175（1）：141-153.
28 Dufu K，Oksenberg D. GBT440 reverses sickling of sickled red blood cells under hypoxic conditions in vitro[J]. Hematol Rep，2018，10（2）：7419.
29 Dufu K，Patel M，Oksenberg D，et al. GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions[J]. Clin Hemorheol Microcirc，2018，70（1）：95-105.
30 Estepp J H. Voxelotor (GBT440)，a first-in-class hemoglobin oxygen-affinity modulator，has promising and reassuring preclinical and clinical data[J]. Am J Hematol，2018，93（3）：326-329.
31 Dufu K，Yalcin O，ESY A，et al. GBT1118，a potent allosteric modifier of hemoglobin O2 affinity，increases tolerance to severe hypoxia in mice[J]. Am J Physiol Heart Circ Physiol，2017，313（2）：H381-H391.
32 Geng X，Dufu K，Hutchaleelaha A，et al. Increased hemoglobin-oxygen affinity ameliorates bleomycin-induced hypoxemia and pulmonary fibrosis[J]. Physiol Rep，2016，4（17）：e12965.
33 Putz N D，Shaver C M，Dufu K，et al. GBT1118，a compound that increases the oxygen affinity of hemoglobin，improves survival in murine hypoxic acute lung injury[J]. J Appl Physiol (1985)，2018，124（4）：899-905.
34 Stücker O，Vicaut E，Villereal M C，et al. Coronary response to large decreases of hemoglobin-O2 affinity in isolated rat heart[J]. Am J Physiol，1985，249(6 Pt 2)：H1224-H1227.
35 Teisseire B，Ropars C，Villeréal M C，et al. Long-term physiological effects of enhanced O2 release by inositol hexaphosphate-loaded erythrocytes[J]. Proc Natl Acad Sci U S A，1987，84（19）：6894-6898.
36 Deleuze P H，Bailleul C，Shiiya N，et al. Enhanced O2 transportation during cardiopulmonary bypass in piglets by the use of inositol hexaphosphate loaded red blood cells[J]. Int J Artif Organs，1992，15（4）：239-242.
37 Huang F，Nojiri H，Shimizu T，et al. Beneficial effect of transfusion with low-affinity red blood cells in endotoxemia[J]. Transfusion，2005，45（11）：1785-1790.
38 Watanabe T，Takeda T，Omiya S，et al. Reduction in hemoglobin-oxygen affinity results in the improvement of exercise capacity in mice with chronic heart failure[J]. J Am Coll Cardiol，2008，52（9）：779-786.
39 Dhar R，Zazulia A R，Derdeyn C P，et al. RBC transfusion improves cerebral oxygen delivery in subarachnoid hemorrhage[J]. Crit Care Med，2017，45（4）：653-659.
40 Sihn G，Walter T，Klein J C，et al. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma[J]. FEBS Lett，2007，581（5）：962-966.
41 Raykov Z，Grekova S P，Bour G，et al. Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy[J]. Int J Cancer，2014，134（11）：2572-2582.
42 Derbal-Wolfrom L，Pencreach E，Saandi T，et al. Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2[J]. Oncogene，2013，32（36）：4313-4318.
43 Limani P，Linecker M，Kachaylo E，et al. Antihypoxic potentiation of standard therapy for experimental colorectal liver metastasis through myo-inositol trispyrophosphate[J]. Clin Cancer Res，2016，22（23）：5887-5897.
44 Aprahamian M，Bour G，Akladios C Y，et al. Myo-inositol trisPyrophosphate treatment leads to HIF-1α suppression and eradication of early hepatoma tumors in rats[J]. Chembiochem，2011，12（5）：777-783.
45 Chen WR，Yu Y，Zulfajri M，et al. Phthalide derivatives from angelica sinensis decrease hemoglobin oxygen affinity: A new allosteric-modulating mechanism and potential use as 2，3-BPG functional substitutes[J]. Sci Rep，2017，7（1）：5504.
46 McKoy M，Allen K，Richards A，et al. Effect of cilostazol on the p50 of the oxygen-hemoglobin dissociation curve[J]. Int J Angiol，2015，24（1）：67-70.
47 Khandelwal S R，Randad R S，Lin P S，et al. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation[J]. Am J Physiol，1993，265(4 Pt 2):H1450-H1453.
48 Kunert M P，Liard J F，Abraham D J，et al. Low-affinity hemoglobin increases tissue PO2 and decreases arteriolar diameter and flow in the rat cremaster muscle[J]. Microvasc Res，1996，52（1）：58-68.
49 Woods J A，Storey C J，Babcock E E，et al. Right-shifting the oxyhemoglobin dissociation curve with RSR13: effects on high-energy phosphates and myocardial recovery after low-flow ischemia[J]. J Cardiovasc Pharmacol，1998，31（3）：359-63.
50 Kilgore K S，Shwartz C F，Gallagher M A，et al. RSR13，a synthetic allosteric modifier of hemoglobin，improves myocardial recovery following hypothermic cardiopulmonary bypass[J]. Circulation，1999，100(19 Suppl)：II351-II356.
51 Weiss R G，Mejia M A，Kass D A，et al. Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity[J]. J Clin Invest，1999，103（5）：739-746.
52 Kleinberg L，Grossman S A，Piantadosi S，et al. Phase I trial to determine the safety，pharmacodynamics，and pharmacokinetics of RSR13，a novel radioenhancer，in newly diagnosed glioblastoma multiforme[J]. J Clin Oncol，1999，17（8）：2593-2603.
53 Miyake M，Grinberg O Y，Hou H，et al. The effect of RSR13，a synthetic allosteric modifier of hemoglobin，on brain tissue pO2 (measured by EPR oximetry) following severe hemorrhagic shock in rats[J]. Adv Exp Med Biol，2003，530：319-329.
54 Suh J H，Stea B，Nabid A，et al. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases[J]. J Clin Oncol，2006，24（1）：106-114.
55 Fylaktakidou K C，Lehn J M，Greferath R，et al. Inositol tripyrophosphate: a new membrane permeant allosteric effector of haemoglobin[J]. Bioorg Med Chem Lett，2005，15（6）：1605-1608.
56 Kieda C，Greferath R，Crola dSC，et al. Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes[J]. Proc Natl Acad Sci U S A，2006，103（42）：15576-15581.

[1]	ZHAO Xing-yun, BIAN Mao-hong. Advances in Research on Relationship between MicroRNAs and Erythroid Growth, Proliferation, Differentiation and Apoptosis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 445-448.
[2]	GUO Hui. The Value of HbA2 and Indexes of Red Blood Cells in Differential Diagnosis of Iron Deficiency Anemia and α-Thalassemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(5): 499-501.
[3]	XIAO Jun, LI Xiao-wei, LIU Juan, et al. Raman Spectroscopy Analysis of Hemoglobin Conformation and Its Correlation with P₅₀ Values [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(2): 113-116.
[4]	LIU Juan, LI Xiao-wei, XIAO Jun, et al. Effects of Different Blood Storage Methods on Oxygen Carrying Function of Red Blood Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(2): 117-119.
[5]	GUO Jie, YOU Guo-xing, ZHANG Ting, et al. Research on The Oxygen Affinity P₅₀ of Red Blood Cell Containing L-Arginine [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(2): 120-123.
[6]	WANG Jin-sheng, ZOU Wei-yang, HUANG Guang-yong, et al. The Significance of Low Hemoglobin Density Combined with RBC Volume Distribution Width for Diagnosis of Small Cell Hypochromic Anemia of Children [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(2): 169-172.
[7]	NIU Yan-liu, PANG Bao-jun, WANG Jian-quan, et al. A Verification of Parameters Reference Intervals of Reticulocyte Tested by Sysmex XN3000 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(2): 208-210.
[8]	REN Li, LUO Qun, LI Xiao-li. Study on The Variation of Hemoglobin in Patients with Orthopedic Internal Fixation Surgery [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(1): 39-41.
[9]	LI Zhen, ZHANG Zhi-fen, HAN Jing-ying, et al. The Clinical Significance of Red Cell Distribution Width （RDW） in Patients with Cerebral Infarction [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(6): 625-628.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(6): 672-676.
[11]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(2): 133-135.
[12]	LIN Hao, HUANG Wen-hua, JIANG Wei-mei, et al. The Study on the Correlation Between the Changes of RBCs Morphology and Injury in the Process of Freezing- thawing-Deglycerolizing [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(2): 141-144.
[13]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(1): 52-53.
[14]	TIAN Min-jie, LI Yan. The New Parameters of Erythrocyte Generated by DXH800 Hematology Analyzer in Clinical Application of Iron Deficiency Anemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(1): 76-79.
[15]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(1): 95-96.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact